Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis

Current Issues in Intestinal Microbiology

Volumn 5, Issue 2, 2004, Pages 59-64

  Bullock, Natalie R ^a   Booth, Jonathan C L ^b   Gibson, Glenn R ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BACTEROIDES; BIFIDOBACTERIUM; CLOSTRIDIUM; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; FECES ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS GASSERI; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; NONHUMAN; PEDIOCOCCUS; REMISSION; SPECIES DIFFERENCE; SPECIES DIVERSITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

ADULT; AGED; BACTERIA; COLITIS, ULCERATIVE; ELECTROPHORESIS; FECES; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINES; LACTOBACILLUS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REMISSION, SPONTANEOUS;

BACTEROIDES; CLOSTRIDIA; LACTOBACILLUS; LACTOBACILLUS MANIHOTIVORANS; LACTOBACILLUS SALIVARIUS; PEDIOCOCCUS; PEDIOCOCCUS ACIDILACTICI; SIGMOIDEA;

EID: 4544348026     PISSN: 1466531X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ballongue, J., Schumann, C. and Quignon, P. (1997). Effects of lactulose and lactitol on colonic microflora and enzyme activity. Scand. J. Gastroentero. 32, 41-44.
2. Bamba, T., Matsuda, H., Endo, M. and Fujiyama, Y. (1995). The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J. Gastroenterol. 30, 45-47.
3. Cashman, K.D. and Shanahan, F. (2003). Is nutrition an aetiological factor for inflammatory bowel disease? Euro. J. Gastroen. Hepat. 15, 607-613.
4. Cresci, A., Orpianesi, C., Silvi, S., Mastrandrea, V. and Dolara, P. (1999). The effect of sucrose or starch-based diet on short-chain fatty acids and faecal microflora in rats. J. Appl. Microbiol. 86, 245-250.
5. Fabia, R., Ar'Rajab, A., Johannson, M.L., Andersson, R., Willen, R., Jeppsson, B., Molin, G. and Bengmark, S. (1993a). Impairment of bacterial-flora in human ulcerative-colitis and experimental colitis in the rat. Digestion 54, 248-255.
6. Fabia, R., Ar'Rajab, A., Johannson, M.L., Willen, R., Andersson, R., Molin, G. and Bengmark, S. (1993b). The effect of exogenous administration of Lactobacillus reuteri R2Lcand oat fiber on acetic-acid-induced colitis in the rat. Scand. J. Gastroentero. 28, 155-62.
7. Ghosh, S., Shand, A., and Ferguson, A. (2000). Regular review - ulcerative colitis. Brit. Med. J. 320, 1119-1123.
8. Gibson, G.R., Macfarlane, G.T. and Cummings, J.H. (1988). Occurrence of sulfate-reducing bacteria in human feces and the relationship of dissimilatory sulfate reduction to methanogenesis in the large gut. J. App. Bacteriol. 65, 103-111.
9. Gill, H.S., Rutherfurd, K.J., Prasad, J. and Gopal, P.K. (2000). Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophillus (HN017) and Bifidobacterium lactis (HN019). Brit. J. Nutr. 83, 167-176.
10. Hans, W., Scholmeric,h J., Gross, V., and Falk, W. (2000). The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur. J. Gastro. Hepatol. 12, 267-273.
11. Ishikawa, H., Akedo, I., Umesaki, Y., Tanaka, R., Imaoka, A. and Otani, T. (2003). Randomised controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J. Am. Coll. Nutr. 22, 56-63.
12. Loubinoux, J., Bronowicki, J.P., Pereira, A.C., Mougenel, J.L. and Le Faou, A.E. (2002). Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microb. Ecol. 40, 107-112.
13. Madsen, K..L, Doyle, J.S., Jewell, L.D., Tavernini, M.M. and Fedorak, N.N. (1999). Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 1107-1114.
14. Madsen, K.L., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., et al. (2001). Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580-591.
15. Maidak, B. L., Olesen, G. J., Larsen, N., Overbeek, R., McCaughey, M. J. and Woese, C. R. (1997). The RDP (Ribosomal Database Project). Nucleic Acids Research 25, 109.
16. Matsuda, H., Fujiyama, Y., Andoh, A., Ushijima, T., Kajinami, T. and Bamba, T. (2000). Charaterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J. Gastroen. Hepatol. 15, 61-68.
17. McBurney, M.I., Thompson, L.U., Cuff, D.J. and Jenkins, D.J.A. (1988). Comparison of ileal effluents, dietary-fibers, and whole foods in predicting the physiological importance of colonic fermentation. Am. J. Gastroenterol. 83, 536-540.
18. McCarthy, J., O'Mahony, L., O'Callaghan, L., Sheil, B., Vaughan, B.B., Fitzsimmons, N., et al. (2003). Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52, 975-980.
19. O'Mahony, L., Feeney, M., O'Halloran, S., Murphy, L., Kiely, B., Fitzgibbon, J., et al. (2001). Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment. Pharm. Therap. 15, 1219-1225.
20. Pathmakanthan, S., Thornley, J.P. and Hawkey, C.J. (1999). Mucosally associated bacterial flora in the human colon: Quantitative and species-specific differences between normal and inflammed colonic biopsies. Gut 44, T121.
21. Perdigon, G., de Macias, M.E., Alvarez, S., Oliver, G. and Holgado, A.A.P.D. (1986). Effect of perorally administered lactobacilli on macrophage activation in mice. Infect. Immun. 53, 404-410.
22. Perdigon, G., Maldonado-Galdeano, C., Valdez, J.C., Medici, M. (2002). Interaction of lactic acid bacteria with the gut immune system. Eur. J. Clin. Nutr. 56, S21-S26.
23. Pitcher, M.C.L., Beatty, E.R. and Cummings, J.H. (2000). The contribution of sulphate reducing bacteria and 5- aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 46, 64-72.
24. Pitcher, M.C.L., Beatty, E.R., Gibson, G.R. and Cummings JH. (1995). Sulphate-reducing bacteria - prevalence in active and inactive ulcerative colitis. Gastroenterology. 108, A894.
25. Pitcher, M.C.L. and Cummings, J.H. (1996). Hydrogen sulphide: A bacterial toxin in ulcerative colitis? Gut 39, 1-4.
26. Probert, C.S., Jayanthi, V., Pinder, D., Wicks, A.C., and Mayberry, J.F. (1992). Epidemiologic-study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 33, 687-693.
27. Rath, H.C., Herfarth, H.H., Ikeda, J.S., Grenther. W.B., Hamm, T.E., Balish, E., et al. (1996). Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta (2) microglobulin transgenic rats. J. Clin. Invest. 98, 945-953.
28. Rath, H.C., Schultz, M., Freitag, R., Dieleman, L.A., Li, F.L., Linde, H.J., et al. (2001). Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 69, 2277-2285.
29. Roediger, W.E., Moore, J. and Babidge, W. (1997). Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Digest. Dis. Sci. 42, 1571-1579.
30. Sanderson, J.D., Moss, M.T., Tizard, M.L.V. and Hermontaylor, J. (1992). Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 33, 890-896.
31. Sartor, R.B., Rath, H.C. and Sellon, R.K. (1996). Microbial factors in chronic intestinal inflammation. Curr. Opin. Gastroen. 12, 327-333.
32. Setoyama, H., Imaoka, A., Ishikawa, H., and Umesaki, Y. (2003). Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients. Microb. Infect. 5, 115-122.
33. Shultz, M., Veltkamp, C., Dieleman, L.A., Grenther, W.B., Wyrick, P.B., Tonkonogy, S.L. and Sartor, R.B. (2002). Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10- deficient mice. Inflamm. Bowel. Dis. 8, 71-80.
34. Suenaga, K., Yokoyama, Y., Nishimori, I., Sano, S., Morito, M., Okasaki, K., et al. (1999). Serum antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Digest. Dis. Sci. 44, 1202-1207.
35. Sutton, C.L., Kim, J., Yamane, A., Dalwadi, H., Wei, B., Landers, C., et al. (2000). Identification of a novel bacteria associated with Crohn's disease. Gastroenterology. 119, 23-31.
36. Venturi, A., Gionchetti, P., Rizzello, F., Johansson, R., Zucconi, E., Bigidi, P., et al. (1999). Impact on the composition of the faecal flora by a new probiotic preparation: preliminiary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharm. Therap. 13, 1103-1108.
37. Walter, J., Hertel, C., Tannock, G.W., Lis, C.M., Munro, K. and Hammes, W.P. (2001). Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weisella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl. Environ. Microb. 67, 2578-2585.
38. Zinkevich, V. and Beech, I.B. (2002). Screening of sulfate- reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa. FEMS Microbiol. Ecol. 34, 147-155.